KRYS logo
KRYS NASDAQ US

Krystal Biotech, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Sep 2017
$260.95
▲ +$2.04 (+0.79%)
Vol 204K
9
Quality Score
ok
Deep Check
2/5 ok
Mkt Cap
$7.1B
P/E
35.9
ROE
19.4%
Margin
53.3%
D/E
0.00
Beta
0.50
52W
$123–$255

Wall Street Consensus

18 analysts · Apr 2026
7
Strong Buy
9
Buy
2
Hold
0
Sell
0
Strong Sell
88.9%
Buy Rating

Price Chart

Similar Stocks

PCVX
Vaxcyte Inc
$6.0B
CYTK
Cytokinetics Inc
$7.8B
NUVL
Nuvalent, Inc
$7.3B
HALO
Halozyme Therapeutics Inc
P/E 13.3
$7.9B
IBRX
Immunitybio Inc
$2.0B
KYMR
Kymera Therapeutics Inc
$6.1B
ACLX
Arcellx Inc
$3.8B

Earnings

Beat rate: 75.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $1.44 $1.70 +$0.26
Sep 2025 $1.11 $2.66 +$1.55
Jun 2025 $1.15 $1.29 +$0.14
Mar 2025 $1.39 $1.20 $-0.19

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) 15.2% 15.2% 15.2% 15.2% 19.4% 19.4%
P/E (TTM) 27.07 28.76 35.62 38.96 31.35 35.94
Net Margin 39.9% 40.9% 40.9% 40.9% 53.3% 53.3%
Gross Margin 92.5% 93.4% 93.4% 93.4% 94.3% 94.3%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 9.68 9.68 9.68 9.68 10.14 10.14

Key Ratios

ROA (TTM)
17.7%
P/S (TTM)
19.16
P/B
4.8
EPS (TTM)
$6.66
CF/Share
$-0.95
52W High
$255.00
52W Low
$122.80
$122.80 52-Week Range $255.00

How does KRYS compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

KRYS AAPG ABEO ABOS ABP

KRYS valuation vs Biotechnology peers

P/E ratio
35.9
▲ 91% above peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
19.2
▲ 49% above peers (12.9)
vs Peers
vs Industry
Pricier
P/B ratio
4.8
▲ 94% above peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

KRYS profitability vs Biotechnology peers

ROE
19.4%
▲ 129% above peers (-67.3%)
vs Peers
vs Industry
Top tier
Net margin
53.3%
▲ 119% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
94.3%
▲ 20% above peers (78.6%)
vs Peers
vs Industry
Weak
ROA
17.7%
▲ 138% above peers (-46.7%)
vs Peers
vs Industry
Top tier

KRYS financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
10.1
▲ 128% above peers (4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.5
▼ 48% below peers (1.0)
vs Peers
vs Industry
More volatile

KRYS fundamentals radar

KRYS Peer median Industry

KRYS profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

KRYS vs peers: key metrics

Latest News

What to Know About This Obesity Drug Developer That Just Drew a …
Yahoo Finance · Mar 18
This Biotech With a Breakout MS Drug Draws $8 Million Investment Amid …
Yahoo Finance · Mar 18